Tetramethylammonium Ion

Tetramethylammonium Ion

SCHEMBL36639

C[N+](C)(C)C.C[N+](C)(C)C.O=P([O-])([O-])O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Tetramethylammonium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC34A1 Q06495 1/20 0.50
CA2 P00918 1/20 0.43
LMNA P02545 3/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35
BBOX1 O75936 3/20 0.35
CHRNB2 P17787 1/20 0.33
CHRNA7 P36544 1/20 0.33
CHRNA4 P43681 1/20 0.33
FDPS P14324 2/20 0.31
GGPS1 O95749 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetramethylammonium Ion SCHEMBL6320658 0.96 SLC34A1 (0.47) SLC34A1CA2LMNAKDM4ECYP2C19
Tetramethylammonium Ion SCHEMBL27744546 0.96 SLC34A1 (0.47) SLC34A1CA2LMNAKDM4ECYP2C19
Tetramethylammonium Ion SCHEMBL36640 0.92 SLC34A1 (0.61) SLC34A1CA2LMNAKDM4ECYP2C19
Tetramethylammonium Ion SCHEMBL27796484 0.88 SLC34A1 (0.57) SLC34A1CA2LMNAKDM4ECYP2C19
Tetramethylammonium Ion SCHEMBL28147271 0.85 SLC34A1 (0.64) SLC34A1CA2LMNAKDM4ECYP2C19
Tetramethylammonium Ion SCHEMBL545336 0.82 CHRNB2 (0.40) SLC34A1LMNABBOX1CHRNB2CHRNA7
Tetramethylammonium Ion SCHEMBL10737257 0.82 CA2 (0.50) SLC34A1CA2LMNAKDM4EBBOX1
Tetramethylammonium Ion SCHEMBL1130116 0.82 SLC34A1 (0.41) SLC34A1CA2LMNAKDM4ECYP2C19
Phosphoric Acid SCHEMBL1116237 0.82
Tetramethylammonium Ion SCHEMBL15924284 0.78 CHRNB2 (0.36) SLC34A1CA2CHRNB2CHRNA7CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260005029-A1 COMPOSITION, METHOD OF TREATING METAL-CONTAINING LAYER BY USING THE SAME, AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE BY USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-01-01 US claimed
EP-3320562-B1 FORMULATIONS TO SELECTIVELY ETCH SILICON GERMANIUM RELATIVE TO GERMANIUM ENTEGRIS INC (US) 2024-08-28 EP claimed
CN-107851660-B Formulations for selective etching of silicon germanium relative to germanium 恩特格里斯公司 2022-02-01 CN claimed
US-10957547-B2 Formulations to selectively etch silicon germanium relative to germanium ENTEGRIS, INC. (US) 2021-03-23 US claimed
EP-3039098-B1 COMPOSITIONS AND METHODS FOR SELECTIVELY ETCHING TITANIUM NITRIDE ENTEGRIS INC (US) 2020-09-30 EP claimed
US-10428271-B2 Compositions and methods for selectively etching titanium nitride ENTEGRIS, INC. (US) 2019-10-01 US claimed
CN-109705010-A A kind of preparation process of high-purity lisinopril 浙江华海药业股份有限公司 2019-05-03 CN claimed
US-20180197746-A1 FORMULATIONS TO SELECTIVELY ETCH SILICON GERMANIUM RELATIVE TO GERMANIUM TRUIST BANK, AS NOTES COLLATERAL AGENT 2018-07-12 US claimed
EP-3320562-A1 FORMULATIONS TO SELECTIVELY ETCH SILICON GERMANIUM RELATIVE TO GERMANIUM Entegris, Inc. (US) 2018-05-16 EP claimed
US-20160200975-A1 COMPOSITIONS AND METHODS FOR SELECTIVELY ETCHING TITANIUM NITRIDE TRUIST BANK, AS NOTES COLLATERAL AGENT 2016-07-14 US claimed
EP-3039098-A1 COMPOSITIONS AND METHODS FOR SELECTIVELY ETCHING TITANIUM NITRIDE Advanced Technology Materials, Inc. (US) 2016-07-06 EP claimed
WO-2016001129-A1 IMPROVED INSECTICIDAL COMPOSITIONS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2016-01-07 WO claimed
WO-2015031620-A1 COMPOSITIONS AND METHODS FOR SELECTIVELY ETCHING TITANIUM NITRIDE ADVANCED TECHNOLOGY MATERIALS, INC. (US) 2015-03-05 WO claimed
CN-103079407-A Improved insecticidal compositions comprising cyclic carboximidamidines BAYER CROPSCIENCE AG 2013-05-01 CN claimed
US-20120004268-A1 INSECTICIDAL COMPOSITIONS COMPRISING CYCLIC CARBONYLAMIDINES BAYER CROPSCIENCE AG (DE) 2012-01-05 US claimed
US-3956171-A Process for preparing stable positively charged alumina coated silica sols and product thereof E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-05-11 US claimed
US-20260098346-A1 COMPOSITION, METHOD OF TREATING METAL-CONTAINING LAYER BY USING THE SAME, AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE BY USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-04-09 US disclosed
US-12547072-B2 Self-aligned build-up processing GEMINATIO, INC. (US) 2026-02-10 US disclosed
WO-1990015170-A1 PRODUCTION OF QUATERNARY AMMONIUM AND QUATERNARY PHOSPHONIUM BOROHYDRIDES SOUTHWESTERN ANALYTICAL CHEMICALS, INC. (US) 1990-12-13 WO disclosed
US-4904357-A Production of quaternary ammonium and quaternary phosphonium borohydrides SOUTHWESTERN ANALYTICAL (US) 1990-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12547072-B2 Self-aligned build-up processing MYBBP1A, SMURF1, MYB SLC34A1 3703/4885CA2 4208/4885LMNA 1133/4885
US-20260098346-A1 COMPOSITION, METHOD OF TREATING METAL-CONTAINING LAYER BY USING THE SAME, AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE BY USING THE SAME AOC2, ASH2L, SCO2 SLC34A1 3349/4885CA2 123/4885LMNA 1282/4885
US-20120004268-A1 INSECTICIDAL COMPOSITIONS COMPRISING CYCLIC CARBONYLAMIDINES DDT, PRMT9, PNISR SLC34A1 1141/4885CA2 532/4885LMNA 2320/4885
US-20260005029-A1 COMPOSITION, METHOD OF TREATING METAL-CONTAINING LAYER BY USING THE SAME, AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE BY USING THE SAME SCO2, ASH2L, AOC2 SLC34A1 3724/4885CA2 88/4885LMNA 1995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.